Health Catalyst, Inc. (Nasdaq: HCAT) recently acquired Carevive Systems, an oncology-focused health technology company based in Boston, MA. The specifics of the deal have not been disclosed, but this acquisition will enable Health Catalyst to enhance its support for care and process improvement in oncology. Additionally, it will provide valuable new insights into patient-reported outcomes and oncology registry data.
Carevive Systems, under the leadership of CEO Bruno Lempernesse, offers a flagship platform that leverages data in routine clinical practice for various purposes such as treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and post-treatment care.
On the other hand, Health Catalyst, led by CEO Dan Burton, is a Salt Lake City-based provider of data and analytics technology and services for healthcare organizations. The company aims to drive substantial, measurable improvements in healthcare by utilizing a cloud-based data platform, analytics software, and professional services expertise. With access to data from over 100 million patient records, Health Catalyst helps its customers make data-informed decisions that lead to tangible clinical, financial, and operational enhancements.
Overall, this acquisition represents a significant step forward for Health Catalyst in their mission to revolutionize healthcare through data and analytics technology.